Etoposide+Cytarabine+PEG-rhG-CSF for Hematopoietic Stem Cell Mobilization in Patients With Hematological Malignancies
Clinical trial NCT05510089 · UNKNOWN
Trial details
- NCT number
- NCT05510089
- Sponsor
- The Affiliated People's Hospital of Ningbo University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2024-05-31
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.